Chris Kepley is an Associate Professor the University of North Carolina at Greensboro (UNCG), Joint School of Nanoscience and Nanoengineering. He is a co-Founder of Kepley BioSystems Incorporated which was formed 2013. He was previously Group Leader of NanoImmunology at Luna Innovations Incorporated. Dr. Kepley is a leading expert in inflammatory mechanisms and using nanomaterials for diagnostic, therapeutic, and theranostic applications. He has over 80 peer-reviewed publications, several issued and pending patents, and serves on the editorial board for several journals. His research was recognized internationally as the recipient of the 2010 Phadia Allergy Research Forum Award, the most prestigious international award in allergy research; and the 2004 Henning Løwenstein International Research Award for excellence in allergy research. More recently he was asked to present his research alongside two Nobel Laureates at the 2015 World Fullerene Conference in Hohhot China. He is a Fellow of the American Academy of Allergy, Asthma and Immunology, serves on the Research Advisory Board for the Food Allergy and Anaphylaxis Network, and is a former Parker B. Francis Fellow in Respiratory Research. Dr. Kepley received his PhD in Microbiology and Immunology from Virginia Commonwealth University, an MBA from the College of William and Mary, and a BS in Biology from James Madison University.